I wouldn't agree on that. The way you formulated it right now ("required"), with a total amount of 600 units of T in a body, you would "require" 1/100 to 1/200 of that to produce "normal" amounts of DHT. In concrete numbers that's 3 to 6 units of T required for x units of DHT.The amount of T required to form DHT is about 1/100 to 1/200 of the total T produced in the body, meaning you need 1 molecule of T from 100 to obtain the amount of DHT present in the body. So, the amount of T needed to form DHT is so small that in the endocrinology filed, this amount of T which is used in the conversion process, is considered not to be a of major significance.
Please remember that serum DHT is a) not the problem and b) a very bad indicator for relevant (i.e. scalp) DHT levels. DHT is produced locally in the skin and scalp, and consumed locally in the skin and scalp again. It will not show up in the serum, or only small parts of the local production of the scalp will spill to the serum.DHT is in blood serum measured in pg / ml, and T in ng / ml. So the amount of DHT is hundreds of time less then the amount of T.
On this I agree.The body naturally does not compensate such small reduction of T.
As result, there is no increase of T in the body, but merely a very small, really small reduction of T.
Also as result, the glands will not necessarily compensate for the use of T in the DHT formation, because T was already produced.
Because, as pointed out above, I think your model for the conversion of T is wrong.I know if you reduce conversion of T to DHT (T - > DHT) Then if I understand simply math there is more amount of T which is not converted to DHT, so as result we have increased level of Testosterone in blood, scalp and etc, but my question is why Propecia raises Testosterone (and therefore because of aromatization Estrogen level) by 10-15 %, if as I just described 1% or even less of T is converted to DHT?
My theory is that the body uses DHT and 5ar to modulate the effects of T selectively. Where the body needs stronger T effects, it produces DHT - but only locally. T is supplied in the serum in an even ditribution, but if the body wants higher effects of T (e.g. for body hair) in one place, what can it do? It can use a metabolite of DHT which is only produced locally and which has 4 to 7 times stronger effect. This way, the body can develop local sexual features even though the base level of the respective hormones is systemically even - the effects only show due to local modulation by 5ar and DHT production. It is local on-demand modulation/amplification of effects, so to say.If that is true why body bothers with DHT production if it can produce sufficient quantities of T when there is lack of DHT ?
.I wouldn't agree on that. The way you formulated it right now ("required"), with a total amount of 600 units of T in a body, you would "require" 1/100 to 1/200 of that to produce "normal" amounts of DHT. In concrete numbers that's 3 to 6 units of T required for x units of DHT.
However, if there's more than 600 units of T you would need less than 1/100 to 1/200 of total T to produce the same amount of DHT. So the "requirement" should not be expressed in relative terms in my opinion. This would also mean that somebody with higher serum T would need more T to produce the same amount of DHT as someone else - this is definitely not the case. Only if you consider the relation between T and DHT, then your equation holds.
.Please remember that serum DHT is a) not the problem and b) a very bad indicator for relevant (i.e. scalp) DHT levels. DHT is produced locally in the skin and scalp, and consumed locally in the skin and scalp again. It will not show up in the serum, or only small parts of the local production of the scalp will spill to the serum.
My theory is that the body uses DHT and 5ar to modulate the effects of T selectively. Where the body needs stronger T effects, it produces DHT - but only locally. T is supplied in the serum in an even distribution, but if the body wants higher effects of T (e.g. for body hair) in one place, what can it do? It can use a metabolite of DHT which is only produced locally and which has 4 to 7 times stronger effect. This way, the body can develop local sexual features even though the base level of the respective hormones is systemically even - the effects only show due to local modulation by 5ar and DHT production. It is local on-demand modulation/amplification of effects, so to say.
If that is true why body bothers with DHT production if it can produce sufficient quantities of T when there is lack of DHT ?
Your absolute numbers were not the problem, but your theory that the body needs a relative amount of its T (no matter how high the specific T value is!) to produce the DHT it requires is the problem.Those numbers I wrote were rough. But can you be more explicit and explain why using finasteride increases systematic T and E level by 15% (According to MERCK those increased values still remain in permitted ranges).
Well, the T producers in our body may be endocrine glands, but the DHT production is, as far as my understanding goes, not endocrine by definition (or at least not completely), but endocrine and autocrine.We agree that in the endocrinology filed, this amount of T which is used in the conversion process to DHT, is considered not to be a of major significance, and in in majority of individuals it definitely isn't 15%, but maybe 2-8%.
Is it because as mentioned in my previous post DHT is 4-7 times more powerful than T (in certain tissues even more). So the body is trying to compensate lack of DHT being created by increasing T.
I don't know this at all, so take the following hypothesis of mine with a huge grain of salt:On the other hand, E increases as T increases to maintain homeostasis ? What is your opinion about that clue ?
If more testosterone is available (because less of it converted to DHT), more estrogen will be produced automatically. Those are to a big extent stochastical processes.Wikipedia said:All of the different forms of estrogen are synthesized from androgens, specifically testosterone and androstenedione, by the enzyme aromatase.
Yes.Yes, I am perfectly aware that probably scalp DHT is what we have to be concerned about, but not serum DHT. With regards to your explanation and theory of role of DHT in local modulation of androgen effects in target tissues it perfectly makes sense. From this it follows scalp and systemic (serum) DHT levels can vary significantly?
Again, its not that simple Please remember that our reproductive organs still provide a "base level" of DHT into our serum. I don't know how much of this base DHT will have an effect in our case (i.e. on the scalp) - but there must be a reason for base DHT, otherwise it would likely not be there.Individuals with lots of body hair should have higher levels of DHT in their skin, even though their serum DHT is in normal ranges.
Partly endocrine (otherwise we wouldnt have serum DHT), partly autocrine.I think you wrote great explanation of role of DHT. So in your opinion DHT is autocrine hormone, but not endocrine hormone like T ? http://en.wikipedia.org/wiki/Autocrine_signalling
Other members here also proposed theory that DHT has effects only in tissues where it is generated. Still there are other gaps in this theory.
Unlike the other things in this post, this is very easy to explain and 100% confirmed: The effect of DHT is exactly that. DHT acts locally - but in many places. Locally in our chest skin (-> chest hair), locally in our scalp (-> Androgenetic Alopecia/male pattern baldness), locally in our reproductive organs (-> libido and ED).It is still fact that people experience sides when using oral DHT inhibitors, like loss of libido, ED, fatigue, even though as you described DHT has effects only in target tissues (scalp, skin, prostate...).
I don't know that, unfortunately. This is one of the three big missing links in Androgenetic Alopecia/male pattern baldness as far as I know.But what control or feedback mechanism decides how many 5ard will be produced in some tissues ?
True observation.Let me ask you this. Can body produce more 5ard when it notice DHT suppression which is result of using finasteride ? In that case we have some kind of endless loop, finasteride inhibits DHT, and body in response produces more of it. Since finasteride and dutasteride in majority of people gives results obviously this is not correct.
As explained above, the body does not increase T production. The 15% increase in serum T levels is very likely only a result of buildup (see above in this post for explanation).That is is why I ask you to explain, why body and its endocrine system simply don't generate more 5ard when using oral or topical finasteride, but rises systemic T by 15%? Wouldn't it be more convenient for body to upregulate production of DHT in tissues where it notice DHT supresion, in our case in scalp when using oral or topical DHT inhibitors ?
A possible explanation for these 15%, though, is not completely related to your model: Even the T bound to SHBG or albumin will sooner or later (more sooner than later) un-bind and be available. Especially in the case of albumin it has been proven that its bound T is basically completely bioavailable. Don't base your model on the small amounts of free T, but include the T that stochastically alternates between a bound and unbound state (in the case of SHBG) and the T that is available anyway although it is bound (in the case of albumin).
Also, take into account that finasteride works systemically. It decreases DHT production all over the body. Can't imagine this would only amount to 0.5 to 1% as you stated with your 1/100 to 1/200 - Wikipedia speaks of at least 5%.
Unless we have any other indicators, I'm pretty sure that the 15% increase in T and E is because this T is simply not converted to DHT due to 5ar inhibition. And while in normal production, 5% of T is converted to DHT, a lack of production may result in a buildup of T - thus, even though only 5% of T is usually is converted, the buildup (simply because there are no consumers for the T surprlusarising from not converting it to DHT) can amount to more than 5%.
Partly endocrine (otherwise we wouldnt have serum DHT), partly autocrine. Unlike the other things in this post, this is very easy to explain and 100% confirmed: The effect of DHT is exactly that. DHT acts locally - but in many places. Locally in our chest skin (-> chest hair), locally in our scalp (-> Androgenetic Alopecia/male pattern baldness), locally in our reproductive organs (-> libido and ED).
Now, finasteride is ingested and distributed through our bloodstream to all target tissues, i.e. all local sites. So while DHT is produced locally in many sites, finasteride works globally on all those local sites. This the reason for its side effects.
Not quite. If it worked that way, you'd have additional 5% for every day you take propecia, e.g. 20% after 4 days, 25% after 5 days, etc., so buildup cannot be linear. But it works similar. A mathematical model for this could be a bounded variant of a logarithmic function, or some other bound function with increasingly small additions depending on time (something like f(x) = sum(t = 0..n, x^(-t)) ). So for each additional period of time, you will have additional buildup - but the addition will be decreasing with time.Let's assume 5% of T is converted to DHT. You clearly explained increase of Free T by 5 % as consequence of non-conversion to DHT. But then, how you came up with 15 %. Is that result of accumulation of free T from several days ago, 15%(at the moment) = 5%(two days ago) + 5%(a day ago) + 5%(present day) ?
Probably yes. We don't have any info that would indicate something different. If there was a feedback path, it will likely only exist for the endocrine production of DHT - how should the body know if there is enough DHT in local tissues?If I correctly understood your explanation, you pointed increase in T (and in E) is directly result of more free T not being converted to DHT. So, In your opinion, which I partially agree, variations of the most essential hormones (T, E) are pure result of more free T because of 5ard inhibition and corresponding stochastic process of fluctuations of T from bounded and unbounded state rather then some kind of feed-back mechanism(compensatory effect) of endocrine system ?
I can't make any statements about their terminology.Another reason which makes difficult to comprehend all this matter are terms and values used in published studies which are not specified correctly. For example in Propecia documentation, it is unclear to me, whether or not T refers to total T or free T?
What makes free testosterone so special in this case, is that according to Merck - (total) testosterone level increases by 10-15% - fooling people to believe that it's actually a good thing. But according to study in this topic: http://www.hairlosstalk.com/interact/showthread.php/54491-Propecia-decreases-bioavailable-testosterone!?p=1032186&viewfull=1#post1032186 total testosterone level goes up, but free testosterone level goes down.
Theory behind that is SHBG has greater affinity for DHT, and second in line is testosterone prior to estrogen, and when you reduce the amount of DHT, testosterone will take the hit. Estrogen is linked to SHBG as well, and more estrogen means more SHBG (women have a lot more SHBG than men). All this makes the estrogen dominance worse. As if that wasn't enough, all these changes causes a chain reaction in the endocrine system. Prolactin is an example of another hormone that increases with estrogen, and it takes a toll on your sexual function. It reduces libido and the intensity of orgasms, and it increases the refraction period. Estrogen dominance is a well known cause for secondary hypogonadism. That said - I could have had an estrogen level that was high before I began treatment - and lowering DHT (which is the natural estrogen antagonist) by 70% would be a very bad idea, if that was the case.
Libido and erectile quality probably depends on a) DHT being within a certain range, i.e. above a required minimum level (if you dont have enough DHT in your body in total, then all local sites will have shortages; in extension, this also applies to T and thus would impair DHT production), and b) hormonal balance. DHT just needs to be above a certain minimum level so that enough is available for all body functions - everything else probably does not play a major role anymore, but only impacts the extent of sexual features. T, however, also needs to be above a certain value so that enough T is available to produce the required amount of DHT for all local sites running their functions.Most men (according to MERCK and other studies) do fine with even decreased bioavailable testosterone. In my opinion, libido / erectile quality is not directly related to the amount of free testosterone in blood, nor is it related to the amount of DHT. The hormonal balance of many people ranges widely and of course lifestyle (diet, stress, amount and quality of sleep, supplements) is probably a big part of it as well.
I partially agree. The part I agree on is that the variations in T and DHT can be dealt with by most men, because they likely have more T and DHT than only the bare minimum their body needs. However, the hormonal balance might have an effect on libido and errections, and the hormonal balance would change when DHT drops - even if DHT is still above the "threshold value".So, in my opinion it isn't like if your free T drops 50%, then your libido and erectile quality will drop by 50% as well. Most men can handle these hormonal variances. I figure that the 2-5% that have side effects with finasteride or dutasteride either already have marginal hormonal levels, or for some reason can't handle ANY decrease in free T or DHT due to their individual genetic make-up.
Yes, both are valid explanations. I wish I could tell which of the two explanations is correct, but both do make sense.It could be that finasteride for some direct or indirect reason increases SHBG in certain people and therefore the free testosterone is bound. It is also a higher possibility that some peoples bodies increase production of aromatase enzyme in order to compensate for the increase in free testosterone which then gets converted to estrogen shifting (FreeT/Estrogen) ratio. This last would explain increase in Estrogen. Since, as I wrote in last post, some say increase in E is result of homeostasis, and some as you believe it is simply because there is more free T, so when you have more free T and less 5ard(competitor for free T), you have more Estrogen.
Abstract
INTRODUCTION:
Our knowledge concerning the effects of testosterone (T) therapy on the skin of trans men (female-to-male transsexuals) is scarce.
AIM:
The aim of this study was to evaluate the short- and long-term clinical effects of T treatment on the skin of trans men.
METHODS:
We conducted a prospective intervention study in 20 hormone naive trans men and a cross-sectional study in 50 trans men with an average of 10 years on T therapy.
MAIN OUTCOME MEASURES:
Acne lesions were assessed using the Gradual Acne Grading Scale, hair patterns using the Ferriman and Gallwey classification (F&G), and androgenetic alopecia using the Norwood Hamilton Scale.
RESULTS:
T treatment increased facial and body hair growth. The F&G score increased progressively from a median value of 0.5 at baseline to a value of 12 after 12 months of T administration. After long-term T treatment, all but one trans man achieved an F&G score indicative of hirsutism in women, with a median value of 24. Only one trans man acquired mild frontotemporal hair loss during the first year of T treatment, whereas 32.7% of trans men had mild frontotemporal hair loss and 31% had moderate to severe androgenetic alopecia after long-term T therapy. The presence and severity of acne increased during the first year of T therapy, and peaked at 6 months. After long-term T treatment, most participants had no or mild acne lesions (93.9%). Dermatological outcome was not demonstrably related to individual serum T or dihydrotestosterone levels.
CONCLUSIONS:
T treatment increased facial and body hair in a time-dependent manner. The prevalence and severity of acne in the majority of trans men peaked 6 months after beginning T therapy. Severe skin problems were absent after short- and long-term T treatment.